- Featured Product
- KD/KO Validated
AMFR/GP78 Polyclonal antibody
AMFR/GP78 Polyclonal Antibody for WB, IHC, IF/ICC, FC (Intra), IP, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA
Conjugate
Unconjugated
Cat no : 16675-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | 37°C incubated HepG2 cells, HepG2 cells, MCF-7 cells |
Positive IP detected in | MCF-7 cells |
Positive IHC detected in | mouse ovary tissue, human kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | HepG2 cells |
Positive FC (Intra) detected in | HepG2 cells |
Positive FC detected in | HepG2 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:8000 |
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
Flow Cytometry (FC) | FC : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
KD/KO | See 9 publications below |
WB | See 29 publications below |
IHC | See 1 publications below |
IF | See 5 publications below |
IP | See 1 publications below |
CoIP | See 2 publications below |
Product Information
16675-1-AP targets AMFR/GP78 in WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | human, mouse, rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | AMFR/GP78 fusion protein Ag10178 相同性解析による交差性が予測される生物種 |
Full Name | autocrine motility factor receptor |
Calculated molecular weight | 643 aa, 73 kDa |
Observed molecular weight | 73 kDa |
GenBank accession number | BC069197 |
Gene symbol | AMFR/GP78 |
Gene ID (NCBI) | 267 |
RRID | AB_2226463 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
AMFR(Autocrine motility factor receptor) is also named as RNF45,gp78.It is the receptor of Autocrine motility factor(AMF),which is a protein secreted by tumor cells that stimulates tumor motility. AMFR has a potential N-glycosylation site, and several potential O-glycosylation sites(PMID:10456327).In normal fibroblasts,the expression of AMFR appeared to be regulated by cell-cell contact(PMID:7626106).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for AMFR/GP78 antibody 16675-1-AP | Download protocol |
IHC protocol for AMFR/GP78 antibody 16675-1-AP | Download protocol |
IF protocol for AMFR/GP78 antibody 16675-1-AP | Download protocol |
IP protocol for AMFR/GP78 antibody 16675-1-AP | Download protocol |
FC protocol for AMFR/GP78 antibody 16675-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cell BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation.
| ||
Immunity The E3 Ubiquitin Ligase AMFR and INSIG1 Bridge the Activation of TBK1 Kinase by Modifying the Adaptor STING.
| ||
PLoS Biol Reticulon and CLIMP-63 regulate nanodomain organization of peripheral ER tubules. | ||
Brief Bioinform Standigm ASK™: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis | ||
EMBO Rep MARCH6 and TRC8 facilitate the quality control of cytosolic and tail-anchored proteins.
| ||
Elife Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
|